Detailed Mechanism Funding and Narrative

Years of mechanism: 2012 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 13636
Country/Region: Kenya
Year: 2016
Main Partner: Johns Hopkins University
Main Partner Program: JHPIEGO
Organizational Type: University
Funding Agency: USAID
Total Funding: $8,690,200 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $1,348,628
Care: Orphans and Vulnerable Children (HKID) $2,488,367
Care: TB/HIV (HVTB) $432,954
Care: Pediatric Care and Support (PDCS) $174,663
Strategic Information (HVSI) $0
Prevention: HIV Testing and Counseling (HVCT) $472,902
Sexual Prevention: Other Sexual Prevention (HVOP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $732,052
Treatment: Adult Treatment (HTXS) $2,523,079
Treatment: Pediatric Treatment (PDTX) $517,555
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV_DSD By PEP service provision (related to sexual violence services provided) 2017 1,044
GEND_GBV_DSD By type of service: Sexual Violence (Post-Rape Care) 2017 1,250
GEND_GBV_DSD Number of people receiving post-GBV care 2017 1,250
HTC_TST_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 52,521
HTC_TST_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 44,330
HTC_TST_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 7,600
HTC_TST_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 7,305
HTC_TST_DSD Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 111,756
HTC_TST_DSD Service Delivery Point (Facility): Outpatient 2017 72,894
HTC_TST_DSD Service Delivery Point (Facility): PMTCT 2017 5,913
HTC_TST_DSD Service Delivery Point (Facility): VCT 2017 32,949
HTC_TST_DSD Sum of Aggregated Age/Sex 15+ 2017 96,851
HTC_TST_DSD Sum of Aggregated Age/Sex <15 2017 14,905
HTC_TST_DSD Sum of Aggregated Age/Sex disaggregates 2017 111,756
HTC_TST_DSD Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 952
HTC_TST_DSD Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 808
HTC_TST_DSD Test Result by Aggregated Age and Sex: Positive <15 Female 2017 186
HTC_TST_DSD Test Result by Aggregated Age and Sex: Positive <15 Male 2017 172
HTC_TST_TA Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 65,516
HTC_TST_TA Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 55,490
HTC_TST_TA Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 6,961
HTC_TST_TA Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 6,631
HTC_TST_TA Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 134,600
HTC_TST_TA Service Delivery Point (Facility): Outpatient 2017 87,655
HTC_TST_TA Service Delivery Point (Facility): PMTCT 2017 6,930
HTC_TST_TA Service Delivery Point (Facility): VCT 2017 40,016
HTC_TST_TA Sum of Aggregated Age/Sex 15+ 2017 121,006
HTC_TST_TA Sum of Aggregated Age/Sex <15 2017 13,592
HTC_TST_TA Sum of Aggregated Age/Sex disaggregates 2017 134,598
HTC_TST_TA Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 1,259
HTC_TST_TA Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 1,073
HTC_TST_TA Test Result by Aggregated Age and Sex: Positive <15 Female 2017 118
HTC_TST_TA Test Result by Aggregated Age and Sex: Positive <15 Male 2017 81
OVC_SERV_DSD Age/Sex: 18+ Female 2017 3,171
OVC_SERV_DSD Age/Sex: 18+ Male 2017 3,057
OVC_SERV_DSD By Aggregated Age/Sex: <18 Female 2017 53,950
OVC_SERV_DSD By Aggregated Age/Sex: <18 Male 2017 52,930
OVC_SERV_DSD Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2017 113,108
OVC_SERV_DSD Sum of Age/Sex disaggregates 2017 6,228
PMTCT_ART_DSD Already on ART at beginning of current pregnancy 2017 597
PMTCT_ART_DSD New on ART 2017 749
PMTCT_ART_DSD Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 74,789
PMTCT_ART_TA Already on ART at beginning of current pregnancy 2017 36
PMTCT_ART_TA New on ART 2017 49
PMTCT_ART_TA Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 7,384
PMTCT_EID_DSD By infants who received a virologic test within 2 months of birth 2017 882
PMTCT_EID_DSD By infants who received their first virologic HIV test between 2 and 12 months of age 2017 312
PMTCT_EID_DSD Number of infants with a positive virological test result within 12 months of birth 2017 46
PMTCT_EID_DSD Number of infants with a positive virological test result within 2 months of birth 2017 12
PMTCT_EID_DSD Sum of Infant Age disaggregates 2017 1,194
PMTCT_EID_TA By infants who received a virologic test within 2 months of birth 2017 7
PMTCT_EID_TA By infants who received their first virologic HIV test between 2 and 12 months of age 2017 2
PMTCT_EID_TA Sum of Infant Age disaggregates 2017 9
PMTCT_STAT_DSD By: Known positives at entry 2017 673
PMTCT_STAT_DSD By: Number of new positives identified 2017 727
PMTCT_STAT_DSD Number of new ANC and L&D clients 2017 74,789
PMTCT_STAT_DSD Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 74,789
PMTCT_STAT_DSD Sum of Positives Status disaggregates 2017 1,400
PMTCT_STAT_TA By: Known positives at entry 2017 38
PMTCT_STAT_TA By: Number of new positives identified 2017 54
PMTCT_STAT_TA Number of new ANC and L&D clients 2017 7,384
PMTCT_STAT_TA Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 7,384
PMTCT_STAT_TA Sum of Positives Status disaggregates 2017 92
TB_ART_DSD Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 600
TB_ART_DSD Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 68
TB_ART_DSD Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 717
TB_ART_DSD Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 81
TB_ART_DSD The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 1,466
TB_ART_DSD The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 1,466
TB_SCREENDX_DSD Screen Result: Screened Positive for TB 2017 3,867
TB_SCREENDX_DSD Screened for TB by Age/Sex: 15+ Female 2017 19,756
TB_SCREENDX_DSD Screened for TB by Age/Sex: 15+ Male 2017 14,311
TB_SCREENDX_DSD Screened for TB by Age/Sex:<15 Female 2017 2,385
TB_SCREENDX_DSD Screened for TB by Age/Sex:<15 Male 2017 2,196
TB_SCREENDX_DSD The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 38,648
TB_SCREENDX_DSD [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 3,867
TB_SCREENDX_DSD [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 3,867
TB_STAT_DSD Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 1,828
TB_STAT_DSD Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 250
TB_STAT_DSD Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 2,133
TB_STAT_DSD Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 297
TB_STAT_DSD Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 4,503
TB_STAT_DSD Total number of registered new and relapsed TB cases, during the reporting period 2017 4,995
TX_CURR_DSD Aggregated Age/Sex: 15+ Female 2017 19,770
TX_CURR_DSD Aggregated Age/Sex: 15+ Male 2017 14,315
TX_CURR_DSD Aggregated Age/Sex: <15 Female 2017 2,374
TX_CURR_DSD Aggregated Age/Sex: <15 Male 2017 2,189
TX_CURR_DSD Number of adults and children receiving antiretroviral therapy (ART) 2017 38,648
TX_CURR_DSD Sum of Aggregated Age/Sex 15+ 2017 34,085
TX_CURR_DSD Sum of Aggregated Age/Sex <15 2017 4,563
TX_CURR_DSD Sum of Aggregated Age/Sex disaggregates 2017 38,648
TX_NEW_DSD Aggregated Grouping by Age/Sex: 15+ Female 2017 2,642
TX_NEW_DSD Aggregated Grouping by Age/Sex: 15+ Male 2017 2,078
TX_NEW_DSD Aggregated Grouping by Age/Sex: <15 Female 2017 278
TX_NEW_DSD Aggregated Grouping by Age/Sex: <15 Male 2017 235
TX_NEW_DSD Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 5,233
TX_NEW_DSD Sum of Aggregated Age/Sex disaggregates 2017 5,233
TX_PVLS_DSD Denominator Aggregated Age/Sex: 15+ Female 2017 19,757
TX_PVLS_DSD Denominator Aggregated Age/Sex: 15+ Male 2017 14,205
TX_PVLS_DSD Denominator Aggregated Age/Sex: <15 Female 2017 2,639
TX_PVLS_DSD Denominator Aggregated Age/Sex: <15 Male 2017 2,219
TX_PVLS_DSD Denominator: Indication: Routine 2017 31,059
TX_PVLS_DSD Denominator: Indication: Targeted 2017 7,761
TX_PVLS_DSD Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 38,820
TX_PVLS_DSD Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 34,785
TX_PVLS_DSD Numerator Aggregated Age/Sex: 15+ Female 2017 17,182
TX_PVLS_DSD Numerator Aggregated Age/Sex: 15+ Male 2017 13,496
TX_PVLS_DSD Numerator Aggregated Age/Sex: <15 Female 2017 2,142
TX_PVLS_DSD Numerator Aggregated Age/Sex: <15 Male 2017 1,965
TX_PVLS_DSD Numerator: Indication: Routine 2017 27,823
TX_PVLS_DSD Numerator: Indication: Targeted 2017 6,962
TX_RET_DSD Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2,932
TX_RET_DSD Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 2,378
TX_RET_DSD Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2,303
TX_RET_DSD Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,842
TX_RET_DSD Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 327
TX_RET_DSD Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 269
TX_RET_DSD Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 284
TX_RET_DSD Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 232
TX_RET_DSD Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 4,721
TX_RET_DSD Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 5,846